Patent Application: Methods for Reducing Blood Lipids Using Plants and Spices
Summary
The USPTO has published a new patent application (US20260083802A1) detailing methods and compositions for reducing blood lipids using plants and spices, specifically Dichrostachys glomerata or Cissus quadrangularis. The application was filed on September 26, 2024.
What changed
This document is a published patent application from the USPTO, not a regulatory rule or guidance. It describes methods and compositions for reducing blood lipids in mammals using specific plant extracts, Dichrostachys glomerata and Cissus quadrangularis. The application, filed on September 26, 2024, outlines potential health benefits including increased GLP-1 levels and reduced visceral fat, food intake, blood lipids, total cholesterol, and total glucose.
As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on entities. However, it signals potential future developments in therapeutic areas related to lipid management and may be of interest to pharmaceutical and biotechnology companies for research and development purposes. Compliance officers in these sectors should be aware of emerging intellectual property in this space.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHODS AND COMPOSITIONS FOR REDUCING BLOOD LIPIDS IN A MAMMAL USING NATURALLY OCCURING PLANTS AND SPICES
Application US20260083802A1 Kind: A1 Mar 26, 2026
Inventors
Shil Kothari, Julius Enyoug Oben
Abstract
Methods and compositions using Dichrostachys glomerata or Cissus quadrangularis separately to provide a variety of health benefits, including but not limited to, increase GLP-1 levels and reduce or decrease visceral fat, food intake, blood lipids, total cholesterol and total glucose in a mammal. In one embodiment, a composition for reducing blood lipids in a mammal is provided where the composition comprises an effective amount of Dichrostachys glomerata provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.
CPC Classifications
A61K 36/48 A61P 3/06 A61K 2236/17 A61K 2236/33
Filing Date
2024-09-26
Application No.
18898614
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.